Morphologic characterization of the patent ductus arteriosus in the premature infant and the choice of transcatheter occlusion device

2015 ◽  
Vol 87 (2) ◽  
pp. 310-317 ◽  
Author(s):  
Ranjit Philip ◽  
B. Rush Waller ◽  
Vijaykumar Agrawal ◽  
Dena Wright ◽  
Alejandro Arevalo ◽  
...  
Keyword(s):  
Patent Ductus Arteriosus ◽  
Premature Infant ◽  
Ductus Arteriosus ◽  
Transcatheter Occlusion ◽  
Occlusion Device ◽  
Patent Ductus

Clinical Analysis of Thrombocytopenia following Transcatheter Occlusion of a Patent Ductus Arteriosus

Cardiology ◽  
2020 ◽  
pp. 1-5
Author(s):  
Ang Li ◽  
Dan Yin ◽  
Xupei Huang ◽  
Lixin Zhang ◽  
Tiewei Lv ◽  
...  
Keyword(s):  
Patent Ductus Arteriosus ◽  
Ductus Arteriosus ◽  
Clinical Analysis ◽  
Good Prognosis ◽  
Severe Thrombocytopenia ◽  
Residual Shunt ◽  
Transcatheter Occlusion ◽  
High Risk Factors ◽  
Median Diameter ◽  
Patent Ductus

<b><i>Background:</i></b> Our aim is to analyze the correlation between severe thrombocytopenia and the diameter of patent ductus arteriosus (PDA) and residual shunt after PDA closure. <b><i>Methods:</i></b> The patients with severe thrombocytopenia (platelet count &#x3c;50 × 10<sup>9</sup>/L) following transcatheter occlusion of a PDA from January 2010 to December 2018 in the Children’s Hospital of Chongqing Medical University were collected. And the high-risk factors, diagnosis, treatment, and prognosis of severe thrombocytopenia were analyzed. <b><i>Results:</i></b> A total of 1,581 children with transcatheter occlusion of a PDA were collected; 22 (1.39%) of the enrolled patients had severe thrombocytopenia. Further data analysis showed that the median diameter of PDA (6.7 [IQR: 1.63]) mm in children with severe thrombocytopenia was significantly larger than that in children without severe thrombocytopenia (3.6 ± 1.7 mm, <i>p</i> &#x3c; 0.001). Furthermore, the incidence of thrombocytopenia in children with residual shunt after operation (10.9%) was significantly higher than that in children without residual shunt (0.2%, <i>p</i> &#x3c; 0.001). The mean time of thrombocytopenia was found to be 2.4 ± 1.3 days after intervention. All patients with thrombocytopenia were treated by methylprednisolone with or without platelet transfusion and recovered without major organ hemorrhage. <b><i>Conclusions:</i></b> Severe thrombocytopenia following transcatheter occlusion of a PDA may be related to the larger diameter of PDA and residual shunt. If early detection of severe thrombocytopenia is obtained, our study supports a good prognosis if appropriate measures are implemented.

Management of Patent Ductus Arteriosus in the Premature Infant: Indomethacin versus Ligation

1983 ◽  
Vol 36 (5) ◽  
pp. 561-566 ◽  
Author(s):  
Constantine Mavroudis ◽  
Larry N. Cook ◽  
Jennifer W. Fleischaker ◽  
Hirikati S. Nagaraj ◽  
Roger J. Shott ◽  
...  
Keyword(s):  
Patent Ductus Arteriosus ◽  
Premature Infant ◽  
Ductus Arteriosus ◽  
Patent Ductus

Transcatheter occlusion of patent ductus arteriosus using coil embolization

1997 ◽  
Vol 60 (2) ◽  
pp. 133-138 ◽  
Author(s):  
José Luiz B Jacob ◽  
Wilson M.C Coelho ◽  
Nilton C.S Machado ◽  
Sérgio A.C Garzon
Keyword(s):  
Patent Ductus Arteriosus ◽  
Coil Embolization ◽  
Ductus Arteriosus ◽  
Transcatheter Occlusion ◽  
Patent Ductus

Transcatheter occlusion of the patent ductus arteriosus: a comparison of two devices

2002 ◽  
Vol 171 (3) ◽  
pp. 151-154
Author(s):  
M. K. El Mallah ◽  
A. J. Sands ◽  
F. A. Casey ◽  
B. G. Craig ◽  
H. C. Mulholland
Keyword(s):  
Patent Ductus Arteriosus ◽  
Ductus Arteriosus ◽  
Transcatheter Occlusion ◽  
Patent Ductus

Gianturco-grifka vascular occlusion device for closure of patent ductus arteriosus

2001 ◽  
Vol 87 (5) ◽  
pp. 657-660 ◽  
Author(s):  
Makram R. Ebeid ◽  
Charles H. Gaymes ◽  
J.Clinton Smith ◽  
David S. Braden ◽  
James A. Joransen
Keyword(s):  
Patent Ductus Arteriosus ◽  
Ductus Arteriosus ◽  
Vascular Occlusion ◽  
Occlusion Device ◽  
Patent Ductus

scholarly journals Mechanical and in vitro evaluation of an experimental canine patent ductus arteriosus occlusion device

2016 ◽  
Vol 59 ◽  
pp. 156-167 ◽  
Author(s):  
Mark A. Wierzbicki ◽  
Jesse Bryant ◽  
Matthew W. Miller ◽  
Brandis Keller ◽  
Duncan J. Maitland
Keyword(s):  
Patent Ductus Arteriosus ◽  
Ductus Arteriosus ◽  
In Vitro Evaluation ◽  
Occlusion Device ◽  
Experimental Canine ◽  
Patent Ductus
Sign in / Sign up

Export Citation Format

Share Document